TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China

<div>The rates of HBeAg seroconversion at the end of follow-up. There was no significant difference in HBeAg seroconversion rates in every time point in the NA-naïve and NA-experienced groups. TDF: tenofovir disoproxil fumarate; NA: nucleos(t)ide analogue.</div>

BioMed Research International

fig4

Figure 4

Figure 4: TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China 